Cited by 14Neuropeptides and Animal PhysiologyPain Mechanisms and TreatmentsRegulation of Appetite and Obesity

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

PACAP up-regulates the expression of apolipoprotein D in 3T3-L1 adipocytes. DRG/3T3-L1 co-cultures study

Kosacka, Joanna, Schröder, Thomas, Bechmann, Ingo, Klöting, Nora, Nowicki, Marcin, Mittag, Anja, Gericke, Martin, Spanel-Borowski, Katharina, Blüher, Matthias·2011·Neuroscience Research

Abstract

The existence of a cross-talk between nerves and fatty tissue is increasingly recognized. Using co-cultures of dorsal root ganglion (DRG)-derived cells and 3T3-L1 adipocytes, we have previously shown that the presence of fat cells enhances neurite outgrowth and number of synapses. Vice versa, neural cells induced expression of neurotrophic adipokines apolipoprotein D and E (ApoD, ApoE) and angiopoietin-1 (Ang-1) by adipocytes. Here, we tested whether pituitary adenylate cyclase-activating peptide (PACAP), which is released by sensory fibres and causes Ca(2+) influx into fat cells, is involved in ApoD induction. Using 3T3-L1 cell cultures, we found that PACAP at a dose of 1 nM up-regulated the expression of ApoD protein and mRNA approx. 2.5 fold. This effect was driven by ERK1/2 acting upon PAC1/VPAC2 receptors. In turn, PACAP-treated 3T3-L1 adipocytes in co-cultures with DRG cells enhanced neurite ramification of neurofilament 200 (NF200)-positive neurons (measured using fluorescence microscopy) and neurofilament 68 protein levels (measured using Western blot analysis). This effect could be blocked using the PAC1/VPAC2 antagonist PACAP(6-38). Scanning cytometry revealed PACAP/ApoD induced low density lipoprotein receptors (LDLR) and ApoE receptor 2 (apoER2) in NF200-positive cells. Thus, a bidirectional loop seems to exist regulating the innervation of fatty tissues: PACAP released from sensory fibres might stimulate fat cells to synthesize neurotrophic adipokines, which, in…

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neures.2010.09.009

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. Akesson, 2003, Dual effects of pituitary adenylate cyclase-activating polypeptide and isoproterenol on lipid metabolism and signaling in primary rat adipocytes, Endocrinology, 144, 5293, 10.1210/en.2003-0364 · DOI
  2. Arimura, 1995, Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction, Front Neuroendocrinol., 16, 53, 10.1006/frne.1995.1003 · DOI
  3. Baccarini, 2005, Second nature: biological functions of the Raf-1 “kinase”, FEBS Lett. Rev., 579, 3271, 10.1016/j.febslet.2005.03.024 · DOI
  4. Boyles, 1990, Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I, J. Biol. Chem., 265, 17805, 10.1016/S0021-9258(18)38235-8 · DOI
  5. Chang, 2001, Mammalian MAP kinase signalling cascades, Nature, 410, 37, 10.1038/35065000 · DOI
  6. Chen, 2006, Neuroprotection by endogenous and exogenous PACAP following stroke, Regul. Pept., 137, 4, 10.1016/j.regpep.2006.06.016 · DOI
  7. Cornelius, 1994, Regulation of adipocyte development, Annu. Rev. Nutr., 14, 99, 10.1146/annurev.nu.14.070194.000531 · DOI
  8. Dickson, 2009, VPAC and PAC receptors: from ligands to function, Pharmacol. Ther. Rev., 121, 294, 10.1016/j.pharmthera.2008.11.006 · DOI
  9. Ernsberger, 2009, Role of neurotrophin signalling in the differentiation of neurons from dorsal root ganglia and sympathetic ganglia, Cell Tissue Res., 336, 349, 10.1007/s00441-009-0784-z · DOI
  10. Ferencz, 2009, Changes and effect of PACAP-38 on intestinal ischemia-reperfusion and autotransplantation, Transpl. Proc., 41, 57, 10.1016/j.transproceed.2008.10.084 · DOI
  11. Fishman, 1987, Sensory innervation of white adipose tissue, Am. J. Physiol. Regul. Integr. Comp. Physiol., 253, R942, 10.1152/ajpregu.1987.253.6.R942 · DOI
  12. Gericke, 2009, Receptors for NPY and PACAP differ in expression and activity during adipogenesis in the murine 3T3-L1 fibroblast cell line, Br. J. Pharmacol., 157, 620, 10.1111/j.1476-5381.2009.00164.x · DOI
  13. Giordano, 1996, Tyrosine hydroxylase, neuropeptide Y, substance P, calcitonin gene-related peptide and vasoactive intestinal peptide in nerves of rat periovarian adipose tissue: an immunohistochemical and ultrastructural investigation, J. Neurocytol., 25, 125, 10.1007/BF02284791 · DOI
  14. Gray, 2001, Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism, Mol. Endocrinol., 15, 1739, 10.1210/me.15.10.1739 · DOI
  15. Gray, 2002, Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide, Endocrinology, 143, 3946, 10.1210/en.2002-220401 · DOI
  16. Jager, 2010, Tpl2 kinase is upregulated in adipose tissue in obesity and may mediate interleukin-1beta and tumor necrosis factor-{alpha} effects on extracellular signal-regulated kinase activation and lipolysis, Diabetes, 59, 61, 10.2337/db09-0470 · DOI
  17. Janke, 2006, Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-gamma activation, J. Hypertens., 24, 1809, 10.1097/01.hjh.0000242405.68461.84 · DOI
  18. Kosacka, 2009, Apolipoproteins D and E3 exert neurotrophic and synaptogenic effects in dorsal root ganglion cell cultures, Neuroscience, 162, 282, 10.1016/j.neuroscience.2009.04.073 · DOI
  19. Kosacka, 2006, Adipocyte-derived angiopoietin-1 supports neurite outgrowth and synaptogenesis of sensory neurons, J. Neurosci. Res., 83, 1160, 10.1002/jnr.20811 · DOI
  20. Laburthe, 2007, Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology, Peptides, 28, 1631, 10.1016/j.peptides.2007.04.026 · DOI
  21. Le Mével, 2009, Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout, J. Exp. Biol., 212, 3919, 10.1242/jeb.035196 · DOI
  22. Lutz, 2006, Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP, Mol. Cell Neurosci., 31, 193, 10.1016/j.mcn.2005.09.008 · DOI
  23. MacDougald, 1995, Transcriptional regulation of gene expression during adipocyte differentiation, Annu. Rev. Biochem., 64, 345, 10.1146/annurev.bi.64.070195.002021 · DOI
  24. Mizuno, 1999, Phosphorylation of extracellular signal-regulated kinases 1 and 2 in 3T3-L1 adipocytes by stimulation of beta (3)-adrenoceptor, Eur. J. Pharmacol., 385, 63, 10.1016/S0014-2999(99)00733-5 · DOI
  25. Mizuno, 2000, The stimulation of beta(3)-adrenoceptor causes phosphorylation of extracellular signal-regulated kinases 1 and 2 through a G(s)- but not G(i)-dependent pathway in 3T3-L1 adipocytes, Eur. J. Pharmacol., 404, 63, 10.1016/S0014-2999(00)00601-4 · DOI
  26. Moller, 1993, Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence, Neuroscience, 57, 725, 10.1016/0306-4522(93)90018-B · DOI
  27. Monaghan, 2008, PACAP-38 induces neuronal differentiation of human SH-SY5Y neuroblastoma cells via cAMP-mediated activation of ERK and p38 MAP kinases, J. Neurochem., 104, 74, 10.1111/j.1471-4159.2007.05018.x · DOI
  28. Nielsen, 2004, PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors, Mol. Cell Neurosci., 25, 629, 10.1016/j.mcn.2003.12.004 · DOI
  29. Nowicki, 2009, Deferoxamine-induced neurite outgrowth and synapse formation in postnatal rat dorsal root ganglion (DRG) cell cultures, Eur. J. Cell Biol., 88, 551, 10.1016/j.ejcb.2009.05.003 · DOI
  30. Parhad, 1995, Axonal atrophy in aging is associated with a decline in neurofilament gene expression, J. Neurosci. Res., 41, 355, 10.1002/jnr.490410308 · DOI
  31. Perdomo, 2010, A role of apolipoprotein D in triglyceride metabolism, J. Lipid Res., 51, 1298, 10.1194/jlr.M001206 · DOI
  32. Roux, 2004, ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions, Microbiol. Mol. Biol. Rev., 320, 10.1128/MMBR.68.2.320-344.2004 · DOI
  33. Shi, 2008, Pituitary adenylate cyclase-activating polypeptide 38-mediated Rin activation requires Src and contributes to the regulation of HSP27 signaling during neuronal differentiation, Mol. Cell Biol., 28, 4940, 10.1128/MCB.02193-07 · DOI
  34. Shi, 2005, Sensory or sympathetic white adipose tissue denervation differentially affects depot growth and cellularity, Am. J. Physiol. Regul. Integr. Comp. Physiol., 288, R1028, 10.1152/ajpregu.00648.2004 · DOI
  35. Suarez, 2006, The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones, Eur. J. Neurosci., 24, 1555, 10.1111/j.1460-9568.2006.05029.x · DOI
  36. Van der Zee, 1989, Expression of growth-associated protein B-50 (GAP43) in dorsal root ganglia and sciatic nerve during regenerative sprouting, J. Neurosci., 9, 3505, 10.1523/JNEUROSCI.09-10-03505.1989 · DOI
  37. Verheijen, 2003, Local regulation of fat metabolism in peripheral nerves, Genes Dev., 17, 2450, 10.1101/gad.1116203 · DOI · Paper page
  38. Wright, 2007, Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db/db) mice, J. Peripher. Nerv. Syst., 12, 250, 10.1111/j.1529-8027.2007.00144.x · DOI
  39. Zhang, 2009, Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk, Neurosci. Res., 63, 205, 10.1016/j.neures.2008.12.010 · DOI
  40. Zhou, 2002, PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways, Curr. Protein Pept. Sci. Rev., 423, 10.2174/1389203023380576 · DOI
  41. Zochodne, 2001, Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes, Brain, 124, 2319, 10.1093/brain/124.11.2319 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kosacka, J., Schröder, T., Bechmann, I., Klöting, N., Nowicki, M., Mittag, A., Gericke, M., Spanel-Borowski, K., & Blüher, M.
Affiliations
Leipzig University (DE)
Corresponding author
Kosacka, Joanna
Venue
Neuroscience Research
Publisher
Elsevier BV
Published
2011-01
Volume
69
Issue
1
Pages
8-16
ISSN
0168-0102 (ISSN-L)
OpenAlex
W2004320859
Cited by
14
References
2
Citations by year
2024: 1 · 2022: 1 · 2021: 1 · 2019: 1 · 2016: 2 · 2015: 1 · 2013: 3 · 2012: 2
FWCI
0.85
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
pituitary adenylate cyclase-activating peptide, apolipoprotein D, adipocytes, dorsal root ganglia, neurite outgrowth, ERK signaling, PAC1 receptor, VPAC2 receptor, PACAP(6-38), LDL receptor, peripheral innervation, adipose tissue innervation
MeSH terms
Animals, Apolipoproteins E, Ganglia, Spinal, Rats, Inbred WF, Synapses, Up-Regulation, Neurites, Neurofilament Proteins, Adipocytes, Coculture Techniques, 3T3-L1 Cells, Angiopoietin-1, Mitogen-Activated Protein Kinase 3, Pituitary Adenylate Cyclase-Activating Polypeptide, Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I, Receptors, Vasoactive Intestinal Peptide, Type II, Mice, Rats, Apolipoproteins D, Adipokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review